平滑筋肉腫(Leiomyosarcoma)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Leiomyosarcoma Overview 6
Therapeutics Development 7
Pipeline Products for Leiomyosarcoma – Overview 7
Pipeline Products for Leiomyosarcoma – Comparative Analysis 8
Leiomyosarcoma – Therapeutics under Development by Companies 9
Leiomyosarcoma – Therapeutics under Investigation by Universities/Institutes 10
Leiomyosarcoma – Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Leiomyosarcoma – Products under Development by Companies 14
Leiomyosarcoma – Products under Investigation by Universities/Institutes 15
Leiomyosarcoma – Companies Involved in Therapeutics Development 16
GlaxoSmithKline plc 16
Karyopharm Therapeutics, Inc. 17
Merck & Co., Inc. 18
Mirati Therapeutics Inc. 19
Novartis AG 20
Pharma Mar, S.A. 21
Leiomyosarcoma – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Target 23
Assessment by Mechanism of Action 25
Assessment by Route of Administration 27
Assessment by Molecule Type 29
Drug Profiles 31
Cell Therapy 2 for Oncology and Infectious Disease – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Cell Therapy to Target LMP-1 and LMP-2 for Oncology – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Cell Therapy to Target LMP-1 and LMP-2 for Oncology and Infectious Diseases – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
everolimus – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
mocetinostat – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
NOV-110501 – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
pazopanib hydrochloride – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
pembrolizumab – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
selinexor – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
trabectedin – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Leiomyosarcoma – Recent Pipeline Updates 60
Leiomyosarcoma – Dormant Projects 83
Leiomyosarcoma – Discontinued Products 84
Appendix 85
Methodology 85
Coverage 85
Secondary Research 85
Primary Research 85
Expert Panel Validation 85
Contact Us 86
Disclaimer 86